# Rent the Runway, Inc.: financial statements, quarterly

RENT · Nasdaq · CIK 1468327 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/rent.md) · [Financials](/companies/rent/financials.md) · [Filings](/companies/rent/filings.md) · [Insiders](/companies/rent/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rent/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-10-31) | Q4 FY2023 (2024-01-31) | Q1 FY2024 (2024-04-30) | Q2 FY2024 (2024-07-31) | Q3 FY2024 (2024-10-31) | Q4 FY2024 (2025-01-31) | Q1 FY2025 (2025-04-30) | Q2 FY2025 (2025-07-31) | Q3 FY2025 (2025-10-31) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [7.8](/filings/0001468327-24-000338.md) | [10.4 d](/filings/0001468327-26-000020.md) | [8.9](/filings/0001468327-25-000097.md) | [10.4](/filings/0001468327-25-000176.md) | [9.6](/filings/0001468327-25-000237.md) | [11.8 d](/filings/0001468327-26-000020.md) | [7.6](/filings/0001468327-26-000031.md) | [11.7](/filings/0001468327-26-000088.md) | [10.6](/filings/0001468327-25-000237.md) | [13.9 d](/filings/0001468327-26-000020.md) | [12.2](/filings/0001468327-26-000031.md) | [13.9](/filings/0001468327-26-000088.md) |
| Cost of revenue | $m | [21.5](/filings/0001468327-24-000338.md) | [20.1 d](/filings/0001468327-26-000020.md) | [20.6](/filings/0001468327-25-000097.md) | [20.6](/filings/0001468327-25-000176.md) | [21.4](/filings/0001468327-25-000237.md) | [20.2 d](/filings/0001468327-26-000020.md) | [20.4](/filings/0001468327-26-000031.md) | [22.5](/filings/0001468327-26-000088.md) | [24.0](/filings/0001468327-25-000237.md) | [21.6 d](/filings/0001468327-26-000020.md) | [23.6](/filings/0001468327-26-000031.md) | [23.5](/filings/0001468327-26-000088.md) |
| Operating income | $m | [(21.9)](/filings/0001468327-24-000338.md) | [(19.3) d](/filings/0001468327-26-000020.md) | [(16.5)](/filings/0001468327-25-000097.md) | [(9.6)](/filings/0001468327-25-000176.md) | [(13.7)](/filings/0001468327-25-000237.md) | [(7.7) d](/filings/0001468327-26-000020.md) | [(19.7)](/filings/0001468327-26-000031.md) | [(20.1)](/filings/0001468327-26-000088.md) | [(16.2)](/filings/0001468327-25-000237.md) | [(1.5) d](/filings/0001468327-26-000020.md) | [(19.7)](/filings/0001468327-26-000031.md) | [(7.8)](/filings/0001468327-26-000088.md) |
| Income tax | $m | [(0.2)](/filings/0001468327-24-000338.md) | [0.5 d](/filings/0001468327-26-000020.md) | [0.0](/filings/0001468327-25-000097.md) | [0.1](/filings/0001468327-25-000176.md) | [0.0](/filings/0001468327-25-000237.md) | [0.2 d](/filings/0001468327-26-000020.md) | [0.2](/filings/0001468327-26-000031.md) | [0.0](/filings/0001468327-26-000088.md) | [0.0](/filings/0001468327-25-000237.md) | [(0.1) d](/filings/0001468327-26-000020.md) | [0.0](/filings/0001468327-26-000031.md) | [0.1](/filings/0001468327-26-000088.md) |
| Net income | $m | [(31.5)](/filings/0001468327-24-000338.md) | [(24.8) d](/filings/0001468327-26-000020.md) | [(22.0)](/filings/0001468327-25-000097.md) | [(15.6)](/filings/0001468327-25-000176.md) | [(18.9)](/filings/0001468327-25-000237.md) | [(13.4) d](/filings/0001468327-26-000020.md) | [(26.1)](/filings/0001468327-26-000031.md) | [(26.4)](/filings/0001468327-26-000088.md) | [76.5](/filings/0001468327-25-000237.md) | [(1.4) d](/filings/0001468327-26-000020.md) | [(18.9)](/filings/0001468327-26-000031.md) | [(12.9)](/filings/0001468327-26-000088.md) |
| Diluted EPS | $ per share | [(9.09)](/filings/0001468327-24-000338.md) | not reported | [(6.03)](/filings/0001468327-25-000097.md) | [(4.17)](/filings/0001468327-25-000176.md) | [(4.70)](/filings/0001468327-25-000237.md) | not reported | [(6.26)](/filings/0001468327-26-000031.md) | [(6.23)](/filings/0001468327-26-000088.md) | [13.65](/filings/0001468327-25-000237.md) | not reported | [(0.57)](/filings/0001468327-26-000031.md) | [(0.38)](/filings/0001468327-26-000088.md) |
| Basic EPS | $ per share | [(9.09)](/filings/0001468327-24-000338.md) | not reported | [(6.03)](/filings/0001468327-25-000097.md) | [(4.17)](/filings/0001468327-25-000176.md) | [(4.70)](/filings/0001468327-25-000237.md) | not reported | [(6.26)](/filings/0001468327-26-000031.md) | [(6.23)](/filings/0001468327-26-000088.md) | [13.69](/filings/0001468327-25-000237.md) | not reported | [(0.57)](/filings/0001468327-26-000031.md) | [(0.38)](/filings/0001468327-26-000088.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-31) | FY2023 (2024-01-31) | Q1 FY2024 (2024-04-30) | Q2 FY2024 (2024-07-31) | Q3 FY2024 (2024-10-31) | FY2024 (2025-01-31) | Q1 FY2025 (2025-04-30) | Q2 FY2025 (2025-07-31) | Q3 FY2025 (2025-10-31) | FY2025 (2026-01-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [106](/filings/0001468327-24-000338.md) | [84.0](/filings/0001468327-26-000020.md) | [82.0](/filings/0001468327-25-000097.md) | [76.6](/filings/0001468327-25-000176.md) | [74.1](/filings/0001468327-25-000237.md) | [77.4](/filings/0001468327-26-000020.md) | [70.4](/filings/0001468327-25-000097.md) | [43.6](/filings/0001468327-25-000176.md) | [50.7](/filings/0001468327-25-000237.md) | [50.4](/filings/0001468327-26-000088.md) | [37.1](/filings/0001468327-26-000031.md) | [29.0](/filings/0001468327-26-000088.md) |
| Current assets | $m | [121](/filings/0001468327-23-000341.md) | [102](/filings/0001468327-25-000056.md) | [99.3](/filings/0001468327-24-000168.md) | [92.6](/filings/0001468327-24-000262.md) | [88.3](/filings/0001468327-24-000338.md) | [93.9](/filings/0001468327-26-000020.md) | [87.1](/filings/0001468327-25-000097.md) | [63.3](/filings/0001468327-25-000176.md) | [66.7](/filings/0001468327-25-000237.md) | [66.7](/filings/0001468327-26-000088.md) | [54.7](/filings/0001468327-26-000031.md) | [44.5](/filings/0001468327-26-000088.md) |
| Total assets | $m | [310](/filings/0001468327-23-000341.md) | [279](/filings/0001468327-25-000056.md) | [278](/filings/0001468327-24-000168.md) | [257](/filings/0001468327-24-000262.md) | [252](/filings/0001468327-24-000338.md) | [240](/filings/0001468327-26-000020.md) | [245](/filings/0001468327-25-000097.md) | [219](/filings/0001468327-25-000176.md) | [231](/filings/0001468327-25-000237.md) | [221](/filings/0001468327-26-000088.md) | [213](/filings/0001468327-26-000031.md) | [192](/filings/0001468327-26-000088.md) |
| Current liabilities | $m | [65.5](/filings/0001468327-23-000341.md) | [48.1](/filings/0001468327-25-000056.md) | [61.6](/filings/0001468327-24-000168.md) | [48.3](/filings/0001468327-24-000262.md) | [53.5](/filings/0001468327-24-000338.md) | [47.4](/filings/0001468327-26-000020.md) | [71.3](/filings/0001468327-25-000097.md) | [68.3](/filings/0001468327-25-000176.md) | [68.6](/filings/0001468327-25-000237.md) | [63.2](/filings/0001468327-26-000088.md) | [72.8](/filings/0001468327-26-000031.md) | [66.1](/filings/0001468327-26-000088.md) |
| Total liabilities | $m | [413](/filings/0001468327-23-000341.md) | [401](/filings/0001468327-25-000056.md) | [420](/filings/0001468327-24-000168.md) | [412](/filings/0001468327-24-000262.md) | [423](/filings/0001468327-24-000338.md) | [423](/filings/0001468327-26-000020.md) | [452](/filings/0001468327-25-000097.md) | [451](/filings/0001468327-25-000176.md) | [266](/filings/0001468327-25-000237.md) | [257](/filings/0001468327-26-000088.md) | [266](/filings/0001468327-26-000031.md) | [258](/filings/0001468327-26-000088.md) |
| Long-term debt | $m | [300](/filings/0001468327-23-000341.md) | [307](/filings/0001468327-25-000056.md) | [313](/filings/0001468327-24-000168.md) | [320](/filings/0001468327-24-000262.md) | [327](/filings/0001468327-24-000338.md) | [334](/filings/0001468327-26-000020.md) | [341](/filings/0001468327-25-000097.md) | [344](/filings/0001468327-25-000176.md) | [159](/filings/0001468327-25-000237.md) | [157](/filings/0001468327-26-000088.md) | [157](/filings/0001468327-26-000031.md) | [158](/filings/0001468327-26-000088.md) |
| Current portion of debt | $m | [0.0](/filings/0001468327-23-000341.md) | [0.0](/filings/0001468327-25-000056.md) | [0.0](/filings/0001468327-24-000168.md) | [0.0](/filings/0001468327-24-000262.md) | [0.0](/filings/0001468327-24-000338.md) | [0.0](/filings/0001468327-26-000020.md) | [0.0](/filings/0001468327-25-000097.md) | [0.0](/filings/0001468327-25-000176.md) | [0.0](/filings/0001468327-25-000237.md) | [0.0](/filings/0001468327-26-000088.md) | [0.0](/filings/0001468327-26-000031.md) | [0.0](/filings/0001468327-26-000088.md) |
| Short-term borrowings | $m | not reported | [1.2](/filings/0001468327-25-000056.md) | [0.7](/filings/0001468327-24-000168.md) | [0.0](/filings/0001468327-24-000262.md) | [0.0](/filings/0001468327-24-000338.md) | [1.4](/filings/0001468327-26-000020.md) | [0.8](/filings/0001468327-25-000097.md) | [0.2](/filings/0001468327-25-000176.md) | [0.8](/filings/0001468327-25-000237.md) | [0.4](/filings/0001468327-26-000088.md) | [0.1](/filings/0001468327-26-000031.md) | [0.0](/filings/0001468327-26-000088.md) |
| Shareholders' equity | $m | [(103)](/filings/0001468327-24-000338.md) | [(122)](/filings/0001468327-26-000020.md) | [(141)](/filings/0001468327-25-000176.md) | [(155)](/filings/0001468327-25-000237.md) | [(171)](/filings/0001468327-25-000237.md) | [(183)](/filings/0001468327-26-000088.md) | [(207)](/filings/0001468327-26-000088.md) | [(232)](/filings/0001468327-26-000088.md) | [(35.1)](/filings/0001468327-25-000237.md) | [(36.1)](/filings/0001468327-26-000088.md) | [(53.3)](/filings/0001468327-26-000088.md) | [(65.5)](/filings/0001468327-26-000088.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-10-31) | Q4 FY2023 (2024-01-31) | Q1 FY2024 (2024-04-30) | Q2 FY2024 (2024-07-31) | Q3 FY2024 (2024-10-31) | Q4 FY2024 (2025-01-31) | Q1 FY2025 (2025-04-30) | Q2 FY2025 (2025-07-31) | Q3 FY2025 (2025-10-31) | Q4 FY2025 (2026-01-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(3.6) d](/filings/0001468327-24-000338.md) | [(8.0) d](/filings/0001468327-26-000020.md) | [4.6](/filings/0001468327-25-000097.md) | [2.2 d](/filings/0001468327-25-000176.md) | [4.7 d](/filings/0001468327-25-000237.md) | [1.4 d](/filings/0001468327-26-000020.md) | [8.3](/filings/0001468327-26-000031.md) | [(10.5) d](/filings/0001468327-26-000088.md) | [(1.4) d](/filings/0001468327-25-000237.md) | [7.1 d](/filings/0001468327-26-000020.md) | [(3.8)](/filings/0001468327-26-000031.md) | [(1.2) d](/filings/0001468327-26-000088.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

## Shares

| Line item | Unit | Q3 FY2022 (2022-10-31) | Q1 FY2023 (2023-04-30) | Q2 FY2023 (2023-07-31) | Q3 FY2023 (2023-10-31) | Q1 FY2024 (2024-04-30) | Q2 FY2024 (2024-07-31) | Q3 FY2024 (2024-10-31) | Q1 FY2025 (2025-04-30) | Q2 FY2025 (2025-07-31) | Q3 FY2025 (2025-10-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [64.5](/filings/0001468327-23-000341.md) | [3.3](/filings/0001468327-24-000168.md) | [3.4](/filings/0001468327-24-000262.md) | [3.5](/filings/0001468327-24-000338.md) | [3.6](/filings/0001468327-25-000097.md) | [3.7](/filings/0001468327-25-000176.md) | [4.0](/filings/0001468327-25-000237.md) | [4.2](/filings/0001468327-26-000031.md) | [4.2](/filings/0001468327-26-000088.md) | [5.6](/filings/0001468327-25-000237.md) | [33.4](/filings/0001468327-26-000031.md) | [33.6](/filings/0001468327-26-000088.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 33,774,121 at 2026-09-04, from the cover of the [10-Q filed 2026-09-11](/filings/0001468327-26-000088.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.